1 Bray Freddie,Ferlay Jacques,Soerjomataram Isabelle et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.[J] .CA Cancer J Clin, 2018, 68: 394-424.
2 Hwang Gi Yong,Baek Dong Won,Cho Hee Jeong et al. Elevated neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with trastuzumab combination chemotherapy.[J] Anticancer Res., 2018, 38: 3151-3156.
3 Suzuki Takashi,Shimada Hideaki,Nanami Tatsuki et al. Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer.[J] Surg. Today, 2016, 46: 1394-1401.
4 Kim Do-Kyong,Oh Sung Yong,Kwon Hyuk-Chan et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer.[J] BMC Cancer, 2009, 9: 155.
5 Fini Mehdi A,Elias Anthony,Johnson Richard J et al. Contribution of uric acid to cancer risk, recurrence, and mortality.[J] Clin Transl Med, 2012, 1: 16.
6 Yang Shanshan,He Xinjia,Liu Ying et al. Prognostic significance of serum uric acid and gamma-glutamyltransferase in patients with advanced gastric cancer.[J] .Dis. Markers, 2019, 2019: 1415421.
7 Chen You-Fang,Li Qiang,Chen Dong-Tai et al. Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy.[J] Cancer Biomark, 2016, 17: 89-96.
8 Dziaman Tomasz,Banaszkiewicz Zbigniew,Roszkowski Krzysztof et al. 8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients.[J] Int. J. Cancer, 2014, 134: 376-83.
9 Stotz Michael,Szkandera Joanna,Seidel Julia et al. Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.[J] PLoS ONE, 2014, 9: e104730.
10 Kawaida Hiromichi,Kono Hiroshi,Amemiya Hidetake et al. Stratification of prognosis in patients with ampullary carcinoma after surgery by preoperative platelet-to-lymphocyte ratio and conventional tumor markers.[J] Anticancer Res., 2019, 39: 6923-6929.
11 Dirican Nigar,Karakaya Yeliz Arman,Gunes Sedat et al. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.[J] Clin Respir J, 2017, 11: 789-796.
12 Wei XB, Chen WJ, Duan CY, et al. Joint effects of uric acid and lymphocyte count on adverse outcomes in elderly patients with rheumatic heart disease undergoing valve replacement surgery. J Thorac Cardiovasc Surg. 2019;158(2):420-427.e1.
13 Yang Zhang,Li Shuangjiang,Zhao Liang et al. Serum uric acid to lymphocyte ratio: A novel prognostic biomarker for surgically resected early-stage lung cancer. A propensity score matching analysis.[J] Clin. Chim. Acta, 2020, 503: 35-44.
14 Li S, Yang Z, Du H, Zhang W, Che G, Liu L. Novel systemic inflammation response index to predict prognosis after thoracoscopic lung cancer surgery: a propensity score-matching study. ANZ J Surg. 2019;89(11):E507-E513.
15 Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858-6862. doi:10.1073/pnas.78.11.6858
16 Strasak AM, Rapp K, Hilbe W, et al. The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women. Ann Oncol. 2007;18(11):1893-1897. doi:10.1093/annonc/mdm338
17 Yan S, Zhang P, Xu W, et al. Serum uric acid increases risk of cancer incidence and mortality: A systematic review and meta-analysis. Mediators Inflamm. 2015;2015:764250. doi:10.1155/2015/764250
18 Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858-6862. doi:10.1073/pnas.78.11.6858
19 Taliaferro-Smith L, Nagalingam A, Zhong D, Zhou W, Saxena NK, Sharma D. LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene. 2009;28(29):2621-2633. doi:10.1038/onc.2009.129
20 Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11(12):886-895. Published 2011
21 Tan S, Radi R, Gaudier F, et al. Physiologic levels of uric acid inhibit xanthine oxidase in human plasma. Pediatr Res. 1993;34(3):303-307.
22 Linder N, Lundin J, Isola J, Lundin M, Raivio KO, Joensuu H. Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer. Clin Cancer Res. 2005;11(12):4372-4381. doi:10.1158/1078-0432.CCR-04-2280
23 Linder N, Haglund C, Lundin M, et al. Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer. J Clin Pathol. 2006;59(9):965-971. doi:10.1136/jcp.2005.032524
24 Linder N, Martelin E, Lundin M, et al. Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells. Eur J Cancer. 2009;45(4):648-655. doi:10.1016/j.ejca.2008.10.036
25 Dunn Gavin P,Old Lloyd J,Schreiber Robert D,The immunobiology of cancer immunosurveillance and immunoediting.[J] Immunity, 2004, 21: 137-48.
26 Ino Y,Yamazaki-Itoh R,Shimada K et al. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.[J] Br. J. Cancer, 2013, 108: 914-23.
27 Lee KH, Kim EY, Yun JS, et al. The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer. BMC Cancer. 2018;18(1):938. Published 2018 Oct 1.
28 Yakovlev P, Klyushin D. Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer. Exp Oncol. 2018;40(2):119-123.
29 Iseki Y, Shibutani M, Maeda K, et al. The impact of the preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer. Surg Today. 2017;47(6):743-754.
30 Tatara Takashi,Suzuki Satoshi,Kanaji Shingo et al. Lymphopenia predicts poor prognosis in older gastric cancer patients after curative gastrectomy.[J] Geriatr Gerontol Int, 2019, 19: 1215-1219.